28例右心系统肿瘤的诊断与外科治疗

目的 探讨右心系统肿瘤的特点，总结其诊断和外科治疗经验。方法 对1989年6月～2006年8月期间的28例右心系统肿瘤患者的临床资料进行回顾性分析。28例中26例在体外循环下行肿瘤切除术，其中17例良性肿瘤均完整切除，同期行三尖瓣DeVega成形术2例，补片修补房间隔或右房壁3例；9例恶性肿瘤因侵及范围广泛，仅行大部切除术。结果 全组28例中26例行手术治疗。手术死亡2例，1例为横纹肌肉瘤术中死于低心排血量综合征，1例为间皮肉瘤术后2d死于低心排血量综合征、多器官功能衰竭。术后2例出现脑栓塞给予相应的治疗，其中1例神经系统症状消失，1例遗留轻度运动障碍。17例良性肿瘤患者中，无远期死亡和复发；9例恶性肿瘤患者中除1例随访时间较短外（〈3个月），其它8例均于术后6个月内死亡。结论 右心系统肿瘤临床少见，恶性率、误诊率高，手术效果和预后均较差。     

甲状腺癌淋巴结微转移的研究

目的:探讨MUC1检测在甲状腺癌淋巴结微转移的可靠性和敏感性。方法:对488例甲状腺疾病手术患者于术前24h用1%美兰1.0~2.0mL注射于甲状腺结节或周围腺体，术中显示蓝染淋巴结，采用RT-PCR法测定临床蓝染淋巴结中的MUC1。 结果:蓝染淋巴结显示率甲状腺癌为93%，良性病例为0。研究组80个蓝染淋巴结中发现有MUC1mＲＮＡ表达的为95%,与病理诊断率(86%)相比有提高（P<0.05）;良性病变（阴性对照组）淋巴结均不存在MUC1mRNA的表达;阳性对照组的癌转移性淋巴结均存在MUC1mRNA的表达。结论:MUC1较病理检查敏感，PCR产物点杂交进一步证实MUC1作为PCR标志物有较好的可靠性。     

Pin1和周期素D1在胰腺癌中的表达及其意义

目的:检测胰腺癌及癌旁组织中Pin1和周期素D1基因的表达,探讨Pin1在胰腺癌发病中所起的作用。方法:收集27例胰腺肿瘤组织及其相应的肿瘤旁组织标本,采用实时荧光定量逆转录聚合酶链反应法（RQ RT-PCR）检测胰腺良恶性肿瘤及肿瘤旁组织中Pin1和周期素D1 mRNA 的表达,运用Fisher精确概率分析两者之间的相关性及其与肿瘤临床分期和病理特征的关系。结果:7例胰腺囊腺瘤中周期素D1和Pin1的表达与肿瘤旁组织之间无显著性差异;而20例胰腺癌中周期素D1和Pin1的表达明显高于肿瘤旁组织［（2.78±1.02）vs.（4.36±1.27）和(5.48±1.69) vs. (9.97±1.86),P<0.05）］。Pin1和周期素D1与肿瘤的临床分期和病理分化程度无明显的相关（组间差异均为P>0.05）,但Pin1与周期素D1的表达有关（P<0.01）。 结论:胰腺癌中Pin1的过表达可促进周期素D1表达,由此诱导了肿瘤的发生;Pin1可能在胰腺癌中起着重要作用。     

膀胱癌的MRI诊断价值

目的:总结膀胱癌的MRI征象,探讨MRI对膀胱癌分期的作用及鉴别诊断要点。方法:对探讨经手术与病理证实23例膀胱癌的MRI回顾性对比分析。其中男性,19例,女性,4例,年龄50~90岁,平均年龄70岁。18例行MRI增强检查。结果:膀胱三角区及膀胱后侧壁是最常见好发部位,表现为膀胱壁突向腔内肿块和(或)膀胱壁局限性不规则增厚;肿瘤平扫T1WI等或略高信号,T2WI呈高信号,Gd-DTPA动态增强早期肿块显著强化。根椐肿瘤生长方式可分为:①小结节型,②广基肿块型,③浸润型。MRI对膀胱癌定位、定性诊断正确率分别为95.7%(22/23)、91.3%(21/23);术前MRI诊断与TNM分期符合率为82.3%(19/23),MRI较病理分期偏高。结论:膀胱癌的MRI表现具有独特性。T1加权主要用于肿瘤的定性诊断,T2加权主要用于肿瘤的术前分期;MRI检查多方位、多序列成像,是显示膀胱癌最理想的检查方法。     

Electrophysiological evaluation in 4 patients with diabetic pseudotabes

BACKGROUND: Researches on diabetic nervous system lesion are mainly focus on peripheral nerve and vegetative nerve, so there are few investigations on diabetic pseudotabes. OBJECTIVE: To investigate the electrophysiological examinations on the diagnosis of diabetic pseudotabes. DESIGN: Case study. SETTING: Department of Electrophysiology and Department of Neurology, Zhongshan Hospital Affiliated to Xiamen University. PARTICIPANTS: A total of 4 patients with type 2 diabetes mellitus, including 3 males and 1 female aged from 50 to 72 years, were selected from Department of Neurology, Zhongshan Hospital Affiliated to Xiamen University from March 2002 to February 2005. All accepted subjects met the modified diagnostic criteria of diabetes mellitus, which was set by American Diabetes Mellitus Association (ADA) in 1997. Otherwise, the subjects had typical symptoms and physical signs of spinal posterior funiculus damage. However, patients with spinal cord lesion which was caused by other factors were excluded. All accepted subjects provided the confirmed consent. METHODS: Nicolet NT electromyography (EMG)/evoked potential meter (made in the USA) was used to detect spinal cord conduction velocity (SCCV), somatosensory evoked potential (SEP) of lower limbs, motor nerve conduction velocity (MNCV) and sensory nerve conduction velocity (SNCV) of extremities. Determining criteria: Measurements were performed based on the laboratory standards. SCCV, which was less than lower limit of normal value (T2–12: 40–55 m/s, T12–L4: 20–41 m/s, T2–L4: 36–45 m/s), was regarded as abnormal. SEP value of lower limbs: P40, P60 and PF, which were more than standard deviation of normal value (x(—)+2.5), were regarded as the abnormality. Normal value of P40, P60 and PF latencies (x(—)±s) in this study: P40, P60 and PF in males were (37.6±1.9) ms, (59.8±3.9) ms and (7.6±0.9) ms, respectively; meanwhile, those in females were (35.5±1.7) ms, (55.2±2.7) ms and (6.3±0.7) ms, respectively. MNCV and SNCV, which were less than 50 m/s in upper limbs and 40 m/s in lower limbs, were regarded as the abnormality. MAIN OUTCOME MEASURES: Electrophysiological examinations. RESULTS: All 4 patients with type 2 diabetes mellitus were involved in the final analysis. ① SCCV: Among 4 patients, SCCV of three patients was decreased in T2–12, T12–L4 and T2–L4, and that of the other one was decreased in T2–12 and T2–L4; however, SCCV in T12–L4 was normal. There was significant difference as compared with normal value (P < 0.01). ② SEP of lower limbs: SEP values of lower limbs were abnormal in all 4 patients. Among them, P40, P60 and PF latencies of two patients were delayed; P40 of one patient was delayed and PF was not drained out; P40 and P60 of the last one were delayed and PF was normal. ③ MNCV and SNCV: The MNCV and SNCV were normal in one patient and abnormal in three patients. The results demonstrated that MNCV and SNCV of extremities decreased; especially, sensory nerve action potential (SNAP) of both lower extremities of one patient were not drained out. CONCLUSION: Detections of SCCV, SEP of lower limbs, MNCV and SNCV of extremities are helpful to investigate whether peripheral nerve and deep sensory passage are damaged or not and determine whether deep sensory damage is caused by peripheral nerve and spinal posterior funiculus.     

神经干细胞移植与脊髓损伤修复

众所周知，脊髓损伤(spinal cord injury，SCI)是临床治疗的世界性难题。以往，许多学者曾尝试周围神经移植、胚胎脊髓移植、雪旺细胞移植、大网膜移植及应用神经营养因子治疗脊髓损伤。这些研究虽有很大进展，但都未达到目的。近年，国内外把研究焦点集中到了具有自我复制能力和多向分化潜能的神经干细胞(neural stem cells，NSCs)上，已取得了一些突破。笔者就脊髓损伤修复和NSCs移植及应用前景作一简介。     

鼻腔鼻窦恶性肿瘤83例报告

目的：评价鼻腔鼻窦恶性肿瘤的治疗方法及其效果。方法：83例原发于鼻腔、上颁窦、筛窦、蝶窦及额窦的恶性肿瘤，分别采用次全与全上颁骨切除、前额开窗一鼻锥翻转进路额筛蝶眶肿瘤大块切除及颅面联合切除，部分病例实施冷冻切除、颌颈朕合根治术等手术治疗以及术后常规放疗等措施。结果：3年生存率为47．5％(36／76)，5年生存率为36．2％(25／69)。结论：鼻腔鼻窦恶性肿瘤通过手术方法的改进以及采用术后放疗等综合治疗，可以提高疗效，但仍需进一步改进治疗方法，提高生存率。     

多层螺旋CT在胰腺癌诊断中的应用

多层螺旋CT（MSCT）使扫描速度，薄层，覆盖范围达到了很好的统一，是胰腺癌最佳的单项检查手段。本文介绍了MSCT运用于胰腺的技术优势以及具体检查方法，重点叙述其在胰腺癌的诊断，术前可切除性的评估等方面的应用。     

兔内听动脉阻断与听觉改变的关系

目的 探讨实验性内听动脉阻断与术后听力改变的关系及术中听觉监控的方法。方法 实验兔乙状窦后进路暴露小脑桥脑角，下压小脑暴露内听道及第Ⅷ神经复合体，分辨出内听动脉，予阻断不同时间，分别行蜗神经直接复合动作电位(DCAP)和畸变产物耳声发射记录(DPOAE)。结果对照组DCAPN1波潜伏期值无明显改变。内耳血供阻断10s和30s组在压迫开始后3min，DCAPN1波潜伏期值均恢复为初始值。内耳血供阻断1min组在压迫开始后3h，DCAPN1波潜伏期值未恢复为初始值假手术组DPOAE幅值无明显改变，内耳血供阻断10s、30s对DPOAE幅值无影响，内耳血供阻断1min使得DPOAE幅值下降结论兔内耳血供阻断1min可能造成兔听觉不可逆损伤。DCAP、DPOAE能有效、持续地监控内耳血供阻断，是耳神经外科手术中实用的听觉监测手段。     

幕上星形细胞肿瘤Ki-67抗原表达及其预后作用

目的 探讨Ki-67抗原在幕上星形细胞肿瘤中的表达及其预后作用。方法 使用S-P免疫组化方法检测82例原发性幕上星形细胞肿瘤标本中Ki-67抗原的表达。单因素使用Kaplan-Meier法,多因素分析使用COX比例风险模型进行预后分析。结果Ki-67 指数在组织学分级GradeⅡ、Ⅲ、Ⅳ中分别为2.86%±1.57%,6.72%±3.95%,8.16%±3.92%(P<0.01)。单因素及多因素分析均提示Ki-67指数是独立的预后因素。在GradeⅡ中,Ki-67指数>2.5%与Grade Ⅲ中Ki-67指数≤2.5%的患者生存期差异无显著性(P>0.05);在GradeⅣ中,Ki-67指数≤2.5%与>2.5%的患者生存期有显著性差异(P<0.01)。结论 Ki-67指数随着各病理级别增高而增高;Ki-67指数>2.5%提示预后较差。在同一病理级别中,Ki-67指数不同,其预后有显著性差异。而部分不同病理级别的患者,随着Ki-67指数的不同,其生存期却无显著差异。联合组织病理检查及Ki-67指数检测有助于更精确地判断预后。